# Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in Humans

> **NCT04130321** · NA · COMPLETED · sponsor: **Laval University** · enrollment: 35 (actual)

## Conditions studied

- Overweight
- Microtia
- Endotoxemia
- Metabolic Syndrome
- Insulin Resistance
- Non-Alcoholic Fatty Liver Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Camu camu
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04130321
- **Lead sponsor:** Laval University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-31
- **Primary completion:** 2022-04-21
- **Final completion:** 2022-04-21
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2022-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04130321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04130321, "Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in Humans". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04130321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*